Research programme: cancer and infectious disease therapeutics - PMV Pharmaceuticals/Chiromics
Latest Information Update: 27 Feb 2014
At a glance
- Originator Chiromics; PMV Pharmaceuticals
- Class Small molecules
- Mechanism of Action Tumour suppressor protein p53 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer; Viral infections
Most Recent Events
- 25 Feb 2014 Early research in Viral infections in USA (unspecified route)
- 25 Feb 2014 Early research in Cancer in USA (unspecified route)